Skip to content
Stroke Association statement on Rivaroxaban

News -

Stroke Association statement on Rivaroxaban

A recent paper published in the BMJ queried the assessment of the ROCKET AF study that the drug Rivaroxaban is effective in reducing Atrial Fibrillation (AF) related stroke. The group who undertook the ROCKET AF study reviewed their data and have now published their finding in the New England Journal of Medicine that Rivaroxaban does not show any increased bleeding risk compared to warfarin. The European Medicines Agency (EMA) concluded the device in the ROCKET AF study did not impact the safety of the drug. 

Alexis Wieroniey, Deputy Director for Policy and Influencing at the Stroke Association said;

“It is very important that medical studies are scrutinised and accountable as all drug therapies carry risk. However, the concerns raised about Rivaroxaban have not affected the licensed use of the drug nor changed the clinical information on its efficacy and safety.

“People taking Rivaroxaban should continue taking their medication to reduce their risk of stroke. If anyone is concerned about Rivaroxaban, they should contact their GP or specialist who should be able to discuss this in more detail for their particular case.”

Topics

Contacts

Angela Macleod

Angela Macleod

Press contact Press Officer National press and Stroke Association research and policy communications 07904 289900
Laura Thomas

Laura Thomas

Press contact Communications Officer Wales 07776508594
Ken Scott

Ken Scott

Press contact Press Officer North of England and Midlands 0115 778 8429
Daisy Dighton

Daisy Dighton

Press contact Press Officer London and East of England 02079401358
Martin Oxley

Martin Oxley

Press contact Press Officer South of England 07776 508 646
Vicki Hall

Vicki Hall

Press contact PR Manager Fundraising and local services 0161 742 7478
Katie Padfield

Katie Padfield

Press contact Head of PR & Media This team is not responsible for booking marketing materials or advertising
Out of hours contact

Out of hours contact

Press contact Media queries 07812388125
Kate Asselman

Kate Asselman

Press contact Artist Liaison Lead 07540 518022
Tell us your story

Tell us your story

Press contact 07799 436008

The UK's leading stroke charity helping people to rebuild their lives after stroke

The Stroke Association. We believe in life after stroke. That’s why we campaign to improve stroke care and support people to make the best possible recovery. It’s why we fund research to develop new treatments and ways to prevent stroke. The Stroke Association is a charity. We rely on your support to change lives and prevent stroke. Together we can conquer stroke.

Stroke Association

240 City Road
EC1V 2PR London
UK